Cargando…

Instrument for assessing mobile technology acceptability in diabetes self-management: a validation and reliability study

BACKGROUND: Nowadays, mobile technologies are part of everyday life, but the lack of instruments to assess their acceptability for the management of chronic diseases makes their actual adoption for this purpose slow. OBJECTIVE: The objective of this study was to develop a survey instrument for asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Frandes, Mirela, Deiac, Anca V, Timar, Bogdan, Lungeanu, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317318/
https://www.ncbi.nlm.nih.gov/pubmed/28243069
http://dx.doi.org/10.2147/PPA.S127922
_version_ 1782508982283272192
author Frandes, Mirela
Deiac, Anca V
Timar, Bogdan
Lungeanu, Diana
author_facet Frandes, Mirela
Deiac, Anca V
Timar, Bogdan
Lungeanu, Diana
author_sort Frandes, Mirela
collection PubMed
description BACKGROUND: Nowadays, mobile technologies are part of everyday life, but the lack of instruments to assess their acceptability for the management of chronic diseases makes their actual adoption for this purpose slow. OBJECTIVE: The objective of this study was to develop a survey instrument for assessing patients’ attitude toward and intention to use mobile technology for diabetes mellitus (DM) self-management, as well as to identify sociodemographic characteristics and quality of life factors that affect them. METHODS: We first conducted the documentation and instrument design phases, which were subsequently followed by the pilot study and instrument validation. Afterward, the instrument was administered 103 patients (median age: 37 years; range: 18–65 years) diagnosed with type 1 or type 2 DM, who accepted to participate in the study. The reliability and construct validity were assessed by computing Cronbach’s alpha and using factor analysis, respectively. RESULTS: The instrument included statements about the actual use of electronic devices for DM management, interaction between patient and physician, attitude toward using mobile technology, and quality of life evaluation. Cronbach’s alpha was 0.9 for attitude toward using mobile technology and 0.97 for attitude toward using mobile device applications for DM self-management. Younger patients (Spearman’s ρ=−0.429; P<0.001) with better glycemic control (Spearman’s ρ=−0.322; P<0.001) and higher education level (Kendall’s τ=0.51; P<0.001) had significantly more favorable attitude toward using mobile assistive applications for DM control. Moreover, patients with a higher quality of life presented a significantly more positive attitude toward using modern technology (Spearman’s ρ=0.466; P<0.001). CONCLUSION: The instrument showed good reliability and internal consistency, making it suitable for measuring the acceptability of mobile technology for DM self-management. Additionally, we found that even if most of the patients showed positive attitude toward mobile applications, only a moderate level of intention to indeed use them was observed. Moreover, the study indicated that barriers were truthfulness and easiness to use.
format Online
Article
Text
id pubmed-5317318
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-53173182017-02-27 Instrument for assessing mobile technology acceptability in diabetes self-management: a validation and reliability study Frandes, Mirela Deiac, Anca V Timar, Bogdan Lungeanu, Diana Patient Prefer Adherence Original Research BACKGROUND: Nowadays, mobile technologies are part of everyday life, but the lack of instruments to assess their acceptability for the management of chronic diseases makes their actual adoption for this purpose slow. OBJECTIVE: The objective of this study was to develop a survey instrument for assessing patients’ attitude toward and intention to use mobile technology for diabetes mellitus (DM) self-management, as well as to identify sociodemographic characteristics and quality of life factors that affect them. METHODS: We first conducted the documentation and instrument design phases, which were subsequently followed by the pilot study and instrument validation. Afterward, the instrument was administered 103 patients (median age: 37 years; range: 18–65 years) diagnosed with type 1 or type 2 DM, who accepted to participate in the study. The reliability and construct validity were assessed by computing Cronbach’s alpha and using factor analysis, respectively. RESULTS: The instrument included statements about the actual use of electronic devices for DM management, interaction between patient and physician, attitude toward using mobile technology, and quality of life evaluation. Cronbach’s alpha was 0.9 for attitude toward using mobile technology and 0.97 for attitude toward using mobile device applications for DM self-management. Younger patients (Spearman’s ρ=−0.429; P<0.001) with better glycemic control (Spearman’s ρ=−0.322; P<0.001) and higher education level (Kendall’s τ=0.51; P<0.001) had significantly more favorable attitude toward using mobile assistive applications for DM control. Moreover, patients with a higher quality of life presented a significantly more positive attitude toward using modern technology (Spearman’s ρ=0.466; P<0.001). CONCLUSION: The instrument showed good reliability and internal consistency, making it suitable for measuring the acceptability of mobile technology for DM self-management. Additionally, we found that even if most of the patients showed positive attitude toward mobile applications, only a moderate level of intention to indeed use them was observed. Moreover, the study indicated that barriers were truthfulness and easiness to use. Dove Medical Press 2017-02-14 /pmc/articles/PMC5317318/ /pubmed/28243069 http://dx.doi.org/10.2147/PPA.S127922 Text en © 2017 Frandes et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Frandes, Mirela
Deiac, Anca V
Timar, Bogdan
Lungeanu, Diana
Instrument for assessing mobile technology acceptability in diabetes self-management: a validation and reliability study
title Instrument for assessing mobile technology acceptability in diabetes self-management: a validation and reliability study
title_full Instrument for assessing mobile technology acceptability in diabetes self-management: a validation and reliability study
title_fullStr Instrument for assessing mobile technology acceptability in diabetes self-management: a validation and reliability study
title_full_unstemmed Instrument for assessing mobile technology acceptability in diabetes self-management: a validation and reliability study
title_short Instrument for assessing mobile technology acceptability in diabetes self-management: a validation and reliability study
title_sort instrument for assessing mobile technology acceptability in diabetes self-management: a validation and reliability study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317318/
https://www.ncbi.nlm.nih.gov/pubmed/28243069
http://dx.doi.org/10.2147/PPA.S127922
work_keys_str_mv AT frandesmirela instrumentforassessingmobiletechnologyacceptabilityindiabetesselfmanagementavalidationandreliabilitystudy
AT deiacancav instrumentforassessingmobiletechnologyacceptabilityindiabetesselfmanagementavalidationandreliabilitystudy
AT timarbogdan instrumentforassessingmobiletechnologyacceptabilityindiabetesselfmanagementavalidationandreliabilitystudy
AT lungeanudiana instrumentforassessingmobiletechnologyacceptabilityindiabetesselfmanagementavalidationandreliabilitystudy